Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 372

A game plan for managing volatility in global equities

The unfortunate reality is that we are in the late stages of an incredibly long bull market in equities, but changes to the ‘growth’ component of a global equity allocation may prove appropriate for investors.

Four types of global equities

Traditionally, Australian investors have achieved growth exposure in their global portfolios by allocating to three buckets of global equities:

1. large cap growth
2. emerging markets
3. global small caps.

It’s not hard to see why. For the better part of the last decade, we have seen large companies - like the FAANG stocks – proving generally to be stellar performers, while emerging markets and global small caps have also performed well for many years.

However, no one was fully prepared for how the COVID-19 pandemic exposed the multitude of risks in global markets.

For those investors who were contemplating changes in global equity portfolios earlier this year but did not act, the recent rally could present a timely opportunity to make some changes to sub-allocations within global equities.

This is where we believe global small and mid-cap (SMID) stocks play an important growth role in diversified portfolios.

Investors have previously not been as aware of this fourth type of asset class as of others. A lack of analyst coverage and investor attention to global SMID stocks has meant that investors have been missing out on an asset class that exhibits strong potential growth opportunity, lower valuation risk than other growth assets and diversification opportunities.

They may not be named brands, like Apple, Facebook, or Google, but what these stocks do offer is an opportunity for investors to access them during their ‘sweet spot’ of the business cycle.

So is it too late to enter the global SMID space for investors?

Allocating to global SMID equities

Global SMID companies can improve the risk-return profile by playing a growth role in investor portfolios over the medium term. They have less valuation risk than large cap growth, less absolute risk than emerging markets and less liquidity risk than small caps alone.

Further, global SMID companies have the best mix of upside and downside capture over 20 years when compared to other global market indices, as shown in Exhibit 1 below. This is an important metric when comparing returns and offers one way to measure expected performance during both market rallies and declines.

An upside capture ratio of greater than 100 indicates historical outperformance of the market during periods of positive returns (the MSCI World SMID Cap Index at 112.50), and a number less than 100 indicates relative underperformance.

Similarly, a downside capture ratio of greater than 100 would indicate a historical decline greater than the broader market during periods of stress, and a downside capture ratio of less than 100 (the MSCI World SMID Cap Index at 99.18), indicates that it historically has protected capital and declined less than the broader market during these negative periods.

Exhibit 1: Upside and Downside Capture (20 years)

Source: eVestment. MSCI Median is the median of the five indices shown in the chart. Period is for 20 years ending June 2020, run on a monthly basis. All results are in AUD terms and measured against MSCI World-ND. 

The remarkable rebound in global equities following the dramatic losses in the first quarter of 2020 has caused many investors to question whether they have ‘missed the boat’ when it comes to investing in global stocks.

The simple answer is no. We believe the current environment makes a good case for an allocation to global SMID stocks.

Valuations have lagged but fundamentals are strong

When we look at global equities as a whole, valuations are not that high, considering the MSCI World Index as a proxy. The current forward price-to-earnings ratio (P/E) is about 20x earnings, or in other words, an earnings yield of about 5%. In the context of a 0% interest rate environment, a 5% earnings yield is reasonable. But within these valuations there is massive dispersion, particularly between large cap growth stocks and value stocks.

Within the global SMID space, there is far less dispersion. As much as stocks have been rebounded off their lows, global SMID stocks have effectively gone sideways over the last three years, lagging the MSCI World Index by 4.2% per annum. As an asset class, they are almost back to where they were in Q3 2017.

In terms of valuations, the MSCI World SMID Cap Index is currently trading on a 2020 P/E of 23.1x, compared to 30.5x for MSCI World Growth Index. As another ‘growth proxy’ in global equity markets, we would argue that a 24% valuation discount is compelling. The absolute P/E of 23.1 might not sound overly cheap in an absolute sense but 2020 earnings will be well below 2019 levels.

We also think investors should acknowledge how valuations have changed over the past five years. Global SMID stocks are currently trading at a 12% premium to the broader market which is in line with its 5-year average. Global large cap growth stocks on the other hand are trading on a 43% premium to the broader market versus its 5-year average of 23%.

This discounted valuation is an attractive proposition for investors seeking diversification potential compared to large cap stocks. 

And while these stocks are not predicted to grow much this year, once we come out of the other side of COVID-19, the organic growth drivers of SMID stocks should come back. The combination of corporate cost-cutting, COVID-19-related stimulus and the reopening of global economies, positions global SMID companies for a strong rebound over the next two to three years.

Companies poised to win in a COVID-19 world

While many industries are suffering because of the COVID-19 pandemic, others have thrived in this environment, especially in the healthcare and consumer discretionary spaces.

The healthcare sector continues to boom, particularly towards research and development in pharmaceuticals and biotech industries. We believe dental orthodontics, which saw a negative impact in the short-term due to lockdowns, will present excellent earnings leverage in 2021.

Stocks that we are watching in the healthcare space include Align Technologies, Idexx Laboratories, and Danish medical devices maker Ambu.

Likewise, consumer discretionary has seen increased demand during COVID-19 as consumer behaviour changes materially. Opportunities include sectors such as home improvements, localised vacations and outdoor activities. However, overseas travel and the hospitality industry will continue to struggle.

Consumer discretionary stocks that we believe are poised to win include Tractor Supply, Pool Corp, O’Reilly Automotive, and YETI Holdings.

For investors looking to diversify their global large cap exposure, global SMID equities present investors with some strong opportunities in names we believe will do well over three to five years and beyond.

 

Ned Bell is Chief Investment Officer and Portfolio Manager at Bell Asset Management, a Channel Capital partner. Channel Capital is a sponsor of Firstlinks. This information is not advice or a recommendation in relation to purchasing or selling particular assets. It does not take into account particular investment objectives or needs.

For more articles and papers from Channel Capital and partners, click here.

 

RELATED ARTICLES

Six COVID opportunist stocks prospering in adversity

What’s the outlook for global small companies?

How to unlock the big opportunity in misunderstood small caps

banner

Most viewed in recent weeks

Australian house prices close in on world record

Sydney is set to become the world’s most expensive city for housing over the next 12 months, a new report shows. Our other major cities aren’t far behind unless there are major changes to improve housing affordability.

The case for the $3 million super tax

The Government's proposed tax has copped a lot of flack though I think it's a reasonable approach to improve the long-term sustainability of superannuation and the retirement income system. Here’s why.

Tariffs are a smokescreen to Trump's real endgame

Behind market volatility and tariff threats lies a deeper strategy. Trump’s real goal isn’t trade reform but managing America's massive debts, preserving bond market confidence, and preparing for potential QE.

The super tax and the defined benefits scandal

Australia's superannuation inequities date back to poor decisions made by Parliament two decades ago. If super for the wealthy needs resetting, so too does the defined benefits schemes for our public servants.

Meg on SMSFs: Withdrawing assets ahead of the $3m super tax

The super tax has caused an almighty scuffle, but for SMSFs impacted by the proposed tax, a big question remains: what should they do now? Here are ideas for those wanting to withdraw money from their SMSF.

Getting rich vs staying rich

Strategies to get rich versus stay rich are markedly different. Here is a look at the five main ways to get rich, including through work, business, investing and luck, as well as those that preserve wealth.

Latest Updates

SMSF strategies

Meg on SMSFs: Withdrawing assets ahead of the $3m super tax

The super tax has caused an almighty scuffle, but for SMSFs impacted by the proposed tax, a big question remains: what should they do now? Here are ideas for those wanting to withdraw money from their SMSF.

Superannuation

The huge cost of super tax concessions

The current net annual cost of superannuation tax subsidies is around $40 billion, growing to more than $110 billion by 2060. These subsidies have always been bad policy, representing a waste of taxpayers' money.

Planning

How to avoid inheritance fights

Inspired by the papal conclave, this explores how families can avoid post-death drama through honest conversations, better planning, and trial runs - so there are no surprises when it really matters.

Superannuation

Super contribution splitting

Super contribution splitting allows couples to divide before-tax contributions to super between spouses, maximizing savings. It’s not for everyone, but in the right circumstances, it can be a smart strategy worth exploring.

Economy

Trump vs Powell: Who will blink first?

The US economy faces an unprecedented clash in leadership styles, but the President and Fed Chair could both take a lesson from the other. Not least because the fiscal and monetary authorities need to work together.

Gold

Credit cuts, rising risks, and the case for gold

Shares trade at steep valuations despite higher risks of a recession. Amid doubts that a 60/40 portfolio can still provide enough protection through times of market stress, gold's record shines bright.

Investment strategies

Buffett acolyte warns passive investors of mediocre future returns

While Chris Bloomstan doesn't have the track record of his hero, it's impressive nonetheless. And he's recently warned that today has uncanny resemblances to the 1990s tech bubble and US returns are likely to be disappointing.

Sponsors

Alliances

© 2025 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.